159 related articles for article (PubMed ID: 16240877)
1. [Current and future medical treatment of Alzheimer's disease].
Lemper JC
Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options in Alzheimer's disease.
Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
[TBL] [Abstract][Full Text] [Related]
5. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
Davidson M; Stern RG
Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
Cummings JL; Mendez MF
Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
[TBL] [Abstract][Full Text] [Related]
7. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
Relkin NR
Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
[TBL] [Abstract][Full Text] [Related]
8. Drugs for treatment of Alzheimer's disease.
Wilkinson D
Int J Clin Pract; 2001 Mar; 55(2):129-34. PubMed ID: 11321852
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical basis for symptomatic treatment of Alzheimer's disease.
Francis PT; Ramírez MJ; Lai MK
Neuropharmacology; 2010; 59(4-5):221-9. PubMed ID: 20156462
[TBL] [Abstract][Full Text] [Related]
10. [Alzheimer's disease: from brain lesions to new drugs].
Forette F; Hauw JJ
Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
[TBL] [Abstract][Full Text] [Related]
11. [Alzheimer's disease: therapeutic perspectives].
Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease: from molecular pathogenesis to innovative therapies.
Scarpini E; Cogiamanian F
Expert Rev Neurother; 2003 Sep; 3(5):619-30. PubMed ID: 19810962
[TBL] [Abstract][Full Text] [Related]
14. Pathology and pathways of Alzheimer's disease with an update on new developments in treatment.
DeKosky ST
J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S314-20. PubMed ID: 12801388
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Alzheimer's Disease cognitive symptoms].
Abel C; Allegri RF; Garau L; Genovese O; Mangone CA
Vertex; 2008; 19 Suppl():39-47. PubMed ID: 18392212
[TBL] [Abstract][Full Text] [Related]
16. Current approaches in the treatment of Alzheimer's disease.
Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
Omerovic M; Hampel H; Teipel SJ; Buerger K
World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
Cummings JL
Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636
[TBL] [Abstract][Full Text] [Related]
19. [Alzheimer's disease. A medical and social challenge].
Forette F
Bull Acad Natl Med; 1996 Oct; 180(7):1731-45; discussion 1745-6. PubMed ID: 9102154
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
